SCOTUS Chat: The Future of Medication Abortion Access

Gender Justice legal and policy experts and the Lawyering Project’s Deputy Executive Director for Legal Programs Amanda Allen discuss the oral arguments in Alliance for Hippocratic Medicine v. Food and Drug Administration (FDA), the Supreme Court case challenging access to medication abortion in the U.S..

Host: Erin Maye Quade, Gender Justice Special Projects Advisor
Guests: Jess Braverman, Gender Justice Legal Director and Amanda Allen, Deputy Executive Director for Legal Programs at The Lawyering Project

Amanda oversees The Lawyering Project’s Access & Innovation Program, which focuses on expanding access to medication abortion through telehealth and other innovative technologies and she brings her years of advocating for meaningful access to reproductive health services to the conversation. In this episode, she joins Gender Justice Legal Director Jess Braverman and Special Projects Advisor Erin Maye Quade to analyze the oral arguments in the case, review the current landscape of medication abortion access, and look ahead to what the future could bring.

References and additional resources:

• Audio of the Supreme Court oral arguments in the case (transcript provided)
• The Lawyering Project
• Gender Justice FAQ on the mifepristone lawsuits
• The UnRestrict Minnesota Guide to Medication Abortion
• The Current Attack on Abortion Pills Will Fail. The Next One Will Be So Much Worse.

About The Gender Justice Brief

The Gender Justice Brief is produced by Gunther Michael Jahnl of IQONEQ Communications Solutions and Audra Grigus.

Visit Gender Justice and UnRestrict Minnesota.